{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"The presence of donor cells is demonstrated by the detection of informative variable-number tandem-repeat polymorphisms or by fluorescent in situ hybridization with a Y-chromosome-specific probe in cases of sex-mismatched transplants. Independent variables that will be examined include donor-recipient KIR mismatch, taking into consideration the interactions with donor-recipient human leukocyte antigen (HLA) compatibility, and the numbers of CD34+ cells and CD3+ cells in the graft.","groups":[{"description":"All patients","id":"OG000","title":"Treatment (Chemotherapy and Allogeneic SCT)"}],"reportingStatus":"POSTED","timeFrame":"Up to 42 days after SCT","title":"Time to the Donor-specific NK-cell Receptor Expression","type":"OTHER_PRE_SPECIFIED"}